HK1204965A1 - 利用氨基吡啶治療中風相關的感覺運動損傷的方法 - Google Patents

利用氨基吡啶治療中風相關的感覺運動損傷的方法

Info

Publication number
HK1204965A1
HK1204965A1 HK15105745.0A HK15105745A HK1204965A1 HK 1204965 A1 HK1204965 A1 HK 1204965A1 HK 15105745 A HK15105745 A HK 15105745A HK 1204965 A1 HK1204965 A1 HK 1204965A1
Authority
HK
Hong Kong
Prior art keywords
aminopyridines
stroke
treating
methods
sensorimotor impairment
Prior art date
Application number
HK15105745.0A
Other languages
English (en)
Inventor
.布萊特
.卡賈諾
湯姆.
.帕里
.亞奇
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of HK1204965A1 publication Critical patent/HK1204965A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK15105745.0A 2011-10-04 2015-06-17 利用氨基吡啶治療中風相關的感覺運動損傷的方法 HK1204965A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161543150P 2011-10-04 2011-10-04
US201261591833P 2012-01-27 2012-01-27
US201261648695P 2012-05-18 2012-05-18
PCT/US2012/058607 WO2013052575A1 (en) 2011-10-04 2012-10-04 Methods for treating a stroke-related sensorimotor impairment using aminopyridines

Publications (1)

Publication Number Publication Date
HK1204965A1 true HK1204965A1 (zh) 2015-12-11

Family

ID=47143280

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15101829.8A HK1201204A1 (zh) 2011-10-04 2015-02-23 利用氨基吡啶治療中風相關的感覺運動損傷的方法
HK15105745.0A HK1204965A1 (zh) 2011-10-04 2015-06-17 利用氨基吡啶治療中風相關的感覺運動損傷的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15101829.8A HK1201204A1 (zh) 2011-10-04 2015-02-23 利用氨基吡啶治療中風相關的感覺運動損傷的方法

Country Status (21)

Country Link
US (2) US20130085167A1 (zh)
EP (1) EP2766017B1 (zh)
JP (1) JP6134722B2 (zh)
KR (1) KR20140084120A (zh)
CN (2) CN104220072B (zh)
AR (1) AR088764A1 (zh)
AU (2) AU2012318719B2 (zh)
BR (1) BR112014008082A8 (zh)
CA (1) CA2850635A1 (zh)
CL (1) CL2014000799A1 (zh)
CO (1) CO7061067A2 (zh)
CR (1) CR20140153A (zh)
EA (1) EA029558B1 (zh)
HK (2) HK1201204A1 (zh)
IL (1) IL231809B (zh)
MX (1) MX354667B (zh)
SG (2) SG10201600410SA (zh)
TW (1) TWI592156B (zh)
UA (1) UA114486C2 (zh)
WO (1) WO2013052575A1 (zh)
ZA (1) ZA201402432B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3427735A1 (en) * 2013-04-15 2019-01-16 Acorda Therapeutics, Inc. Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
CN106511293B (zh) * 2015-09-11 2020-08-04 法德生技药品股份有限公司 含有达方吡啶的缓释口服制剂及其用途
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN109172573B (zh) * 2018-09-12 2021-01-26 黑龙江中桂制药有限公司 一种口服抗血栓药物及其用途
CN115018836A (zh) * 2022-08-08 2022-09-06 四川大学 一种癫痫病灶自动分割与预测方法、系统及设备

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 4−アミノピリジン誘導体及びその酸付加塩
EP0408650A1 (en) * 1988-04-08 1991-01-23 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
AU3360000A (en) * 1999-02-09 2000-08-29 Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
AU2001242184A1 (en) * 2000-03-28 2001-10-08 Queen:S University At Kingston Methods for effecting neuroprotection using a potassium channel modulator
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
US20100095132A1 (en) * 2007-01-26 2010-04-15 Safenet, Inc. Protecting secrets in an untrusted recipient
US20130030025A1 (en) * 2011-01-28 2013-01-31 Wessel Thomas C Use of potassium channel blockers to treat cerebral palsy

Also Published As

Publication number Publication date
AU2018200114A1 (en) 2018-01-25
CN104220072B (zh) 2018-04-17
CN108451953A (zh) 2018-08-28
UA114486C2 (uk) 2017-06-26
EP2766017A1 (en) 2014-08-20
EA201490562A1 (ru) 2014-08-29
IL231809B (en) 2019-06-30
CN104220072A (zh) 2014-12-17
AU2012318719B2 (en) 2017-10-19
SG11201401248YA (en) 2014-05-29
EP2766017B1 (en) 2020-07-01
CA2850635A1 (en) 2013-04-11
HK1201204A1 (zh) 2015-08-28
US20130085167A1 (en) 2013-04-04
JP2014531470A (ja) 2014-11-27
KR20140084120A (ko) 2014-07-04
IL231809A0 (en) 2014-05-28
JP6134722B2 (ja) 2017-05-24
US20160067232A1 (en) 2016-03-10
EA029558B1 (ru) 2018-04-30
CR20140153A (es) 2014-07-04
SG10201600410SA (en) 2016-02-26
TW201321000A (zh) 2013-06-01
BR112014008082A2 (pt) 2017-07-18
NZ623255A (en) 2016-08-26
MX2014003997A (es) 2014-07-22
CO7061067A2 (es) 2014-09-19
ZA201402432B (en) 2020-08-26
BR112014008082A8 (pt) 2018-01-16
AR088764A1 (es) 2014-07-02
CL2014000799A1 (es) 2014-11-03
AU2012318719A1 (en) 2014-04-17
WO2013052575A1 (en) 2013-04-11
MX354667B (es) 2018-03-15
TWI592156B (zh) 2017-07-21

Similar Documents

Publication Publication Date Title
EP2774098C0 (en) AUTHENTICATION PROCESS
EP2689416A4 (en) COMMUNICATION APPARATUS
HK1203215A1 (zh) 使用農桿菌改善轉化的方法
PT3448035T (pt) Método e aparelho para a realização de intrapredição utilizando um filtro adaptativo
GB201111595D0 (en) Improved process
GB201103499D0 (en) Process
GB201107072D0 (en) Process
ZA201208219B (en) Method for treating wasterwater
EP2770665A4 (en) METHOD FOR CREATING A GROUP
GB201101370D0 (en) Process
EP2670712A4 (en) TREATMENT PROCEDURE FOR THE RECOVERY OF BOR
HK1204965A1 (zh) 利用氨基吡啶治療中風相關的感覺運動損傷的方法
EP2692927A4 (en) METHOD FOR PRODUCING ELASTIC PANELS
GB201112051D0 (en) Process
EP2692926A4 (en) METHOD FOR PRODUCING ELASTIC PANELS
GB2488097B (en) Printing process
EP2794810A4 (en) OIL PRODUCTION PROCESS
EP2705248A4 (en) ENERGY RECOVERY ARRANGEMENT
GB201402836D0 (en) Recovery valve
GB2490171B (en) Recovery method
GB201103092D0 (en) Process
IL211020A0 (en) A method for treating a lignin stream
GB201105395D0 (en) A method
PL394576A1 (pl) Sposób wykonania mozaiki
GB201113638D0 (en) Hydrocarbon recovery

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231011